Hereditary Haemochromatosis Flashcards
What is hereditary haemochromatosis (HH)?
An inherited disorder of iron metabolism.
There is increased intestinal iron absorption leading to iron depositions in many organs.
Epidemiology of HH.
Middle-aged men are more frequently and severely affected than women.
In women the disease tends to present around 10 years later (this because menstrual blood loss is protective)
Organs where depositions of iron are made.
Liver
Joints
Heart
Pancreas
Pituitary
Adrenals
Skin
Genetics of HH.
One of the most common inherited conditions in those of northern european origin.
It is autosomal recessive.
Most HH are due to a mutation in HFE gene.
Hepcidin mutation can also cause it but this is rare.
Early clinical features of HH.
Asymptomatic
Tiredness
Arthralgia of 2nd and 3rd MCP joints and knee pseudogout
Decreased libido
Later clinical features of HH.
Slate-grey skin pigmentation
Signs of chronic liver disease
Hepatomegaly
Cirrhosis
Dilated cardiomyopathy
Endocrinopathies related to HH.
DM (bronze diabetes from iron deposition in pancreas)
Hypogonadism due to decreased pituitary function
Investigations in HH.
LFTs
Ferritin
Iron
Genotyping
Imaging
Liver biopsy
Blood findings in HH.
Increased LFTs
Increased ferritin (inflammation also increases ferritin)
Increased transferrin saturation
HFE genotyping
Imaging findings of HH.
Chondrocalcinosis
Liver and cardiac MRI can show FE overload
Findings on liver biopsy.
Perl’s stain quantifies iron loading
This also assesses disease severity
Types of management of HH.
Venesection
Monitoring
Over the counter drugs
Diet
Screening
Explain venesection treatment in HH.
0.5-2 units of blood every 1-2 weeks.
This is until ferritin is less than 50 mcg/L - this can take as long as 2 years to achieve.
The iron will still accumulate so maintenance venesection is needed for life.
1 unit every 2-3 months to maintain haematocrit < 0.5, ferritin < 100mcg/L and transferrin saturation < 40%.
What can be considered if the patient is intolerant to venesections?
Desferrioxamine (iron-chelating agent)
Monitoring of HH.
LFTs and glucose/diabetes
HbA1c levels may be falsely low as venesection decreases the time available for Hb glycosylation so it is not reliable.
If cirrhotic screen for HCC by USS and AFP twice yearly